高科技意味着高回报,也伴随着高风险。
我们超越实验室通过三轮超智慧投资模式为投资人降低风险,争取利益的最大化:
超越实验室高学历的专业团队为大家精心挑选投资机会;我们挑选的大部分投资项目都是牛津剑桥伦敦等高校独立出来的公司,代表了科技的最高水准和产品的独一无二性。
在通过我们超越第一轮筛选后,我们会邀请高级顾问对投资项目进行第二轮独立的评论。投资的项目可能涉及非常复杂的技术和高深的科学,所以我们要通过专家在特定领域的全面知识和丰富经验来理解被投公司的最大的商业潜力,帮助我们做出正取的判断,减少风险。
经验丰富的天使投资人或是风投机构会给希望投资的项目先做一个全面的专业的尽职调查,排除财务和法律上的风险。然后他们会利用他们的资源和经验于公司就股价和股东权益进行谈判,最终取得合适的投资条款,第一个做出投资。在我们超越平台上,我们领队大哥会和大家分享他们的投资心得并和大家深度讨论。最重要的是其他跟投的朋友们可以享受和领队大哥一样的股价和股东权益,从而降低风险,取得最大的投资回报。
Beyond Laboratory Ltd (Beyond Lab), was established in 2014 and aims to build a bridge between companies in the UK and Chinese investors. Different to other investment agents, Beyond Lab is a UK company created by scientists for scientists. We focus on the medical/health related sectors including Life Sciences, Medical technology and devices, Healthcare and Pharmaceuticals. Our expertise includes Cancer Research, Diabetes, Neurosciences and Healthcare Software Solutions. We bring the British companies and Chinese investors together and help them to build up a long-term, win-win business partnership.
Beyond Lab.
31 Old Burlington Street
Mayfair
London, W1S 3AS
Disclaimer
Beyondlaboratory Ltd (BL) is unregulated company acting within exemptions set out within the Financial Services and Markets Act (“the Act”) in order to enable parties to communicate and to act as an introducer. CIC facilitates UK businesses seeking funding to present their businesses to Chinese individuals and companies which are looking to fund companies or otherwise cooperate with them in any number of ways. Beyondlaboratory Ltd does not give any assurance that the business presenting in this document is suitable for investment and that funding is appropriate. Accordingly investors should conduct their own due diligence and consult their legal, financial and tax advisers before entering into any contractual obligation with this business.